cyc 202 has been researched along with osilodrostat in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (osilodrostat) | Trials (osilodrostat) | Recent Studies (post-2010) (osilodrostat) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 77 | 12 | 76 |
| Protein | Taxonomy | cyc 202 (IC50) | osilodrostat (IC50) |
|---|---|---|---|
| Steroid 17-alpha-hydroxylase/17,20 lyase | Homo sapiens (human) | 3.9811 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.0002 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0029 | |
| Aromatase | Homo sapiens (human) | 2.1109 | |
| Cytochrome P450 11B1, mitochondrial | Rattus norvegicus (Norway rat) | 0.495 | |
| Cytochrome P450 11B1, mitochondrial | Homo sapiens (human) | 0.0053 | |
| Cytochrome P450 11B2, mitochondrial | Mus musculus (house mouse) | 0.21 | |
| Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | 0.0014 | |
| Cytochrome P450 11B2, mitochondrial | Rattus norvegicus (Norway rat) | 0.111 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.0002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feelders, RA; Hofland, LJ; Lacroix, A; Newell-Price, J; Nieman, LK; Pivonello, R | 1 |
1 review(s) available for cyc 202 and osilodrostat
| Article | Year |
|---|---|
Advances in the medical treatment of Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenal Gland Neoplasms; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cabergoline; Cushing Syndrome; Dopamine Agonists; ErbB Receptors; Gefitinib; Hormones; Humans; Imidazoles; Isoquinolines; Molecular Targeted Therapy; Pituitary ACTH Hypersecretion; Pyrazoles; Pyridines; Receptors, Glucocorticoid; Roscovitine; Somatostatin; Temozolomide; Tretinoin | 2019 |